Moreover, a noteworthy observation emerged: BCAA levels already exhibited a reduction at the stage of microproteinuria (DKD group-1) in contrast to the DM group, with a progressive decline in BCAA levels noted with the advancement of DKD. The gene discussed is ARID4B; the disease is diabetic kidney disease.